References
- Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–360.
- Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.
- Rooy M-J, Pretorius E. Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events. CMC. 2014;21(19):2121–2129.
- Wilkinson KD, Urban MK, Haas AL. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J Biol Chem. 1980;255(16):7529–7532.
- Haglund K, Dikic I. The role of ubiquitylation in receptor endocytosis and endosomal sorting. J Biol Chem. 2012;125:265–275.
- Haglund K, Dikic I. Ubiquitylation and cell signaling. Embo J. 2005;24(19):3353–3359.
- Ryu K-Y, Sinnar SA, Reinholdt LG, et al. The mouse polyubiquitin gene Ubb is essential for meiotic progression. Mol Cell Biol. 2008;28(3):1136–1146.
- Baker TA, Davis CS, Bach HH 4th, et al. Ubiquitin and stromal cell-derived factor-1alpha in bronchoalveolar lavage fluid after burn and inhalation injury. J Burn Care Res. 2012;33(1):57–64.
- Majetschak M, King DR, Krehmeier U, et al. Ubiquitin immunoreactivity in cerebrospinal fluid after traumatic brain injury: clinical and experimental findings. Crit Care Med. 2005;33(7):1589–1594.
- Okada M, Miyazaki S, Hirasawa Y. Increase in plasma concentration of ubiquitin in dialysis patients: possible involvement in beta 2-microglobulin amyloidosis. Clin Chim Acta. 1993;220(2):135–144.
- Majetschak M, Zedler S, Hostmann A, et al. Systemic ubiquitin release after blunt trauma and burns: association with injury severity, posttraumatic complications, and survival. J Trauma. 2008;64(3):586–596.
- Asseman C, Pancre V, Delanoye A, et al. A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases. J Immunol Methods. 1994;173(1):93–101.
- Leiblein M, Ponelies N, Johnson T, et al. Increased extracellular ubiquitin in surgical wound fluid provides a chemotactic signal for myeloid dendritic cells. Eur J Trauma Emerg Surg. 2018;1–11.
- Kieffer AE, Goumon Y, Ruh O, et al. The N- and C-terminal fragments of ubiquitin are important for the antimicrobial activities. Faseb J. 2003;17(6):776–778.
- Szewczuk Z, Stefanowicz P, Wilczyński A, et al. Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence. Biopolymers. 2004;74(5):352–362.
- Cao Y, Li C, Zhang Q, et al. Extracellular ubiquitin enhances the suppressive effects of regulatory T cells on effector T cell responses. Clin Lab. 2014;60(12):1983–1991.
- Daino H, Matsumura I, Takada K, et al. Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells. Blood. 2000;95(8):2577–2585.
- Earle SA, El-Haddad A, Patel MB, et al. Prolongation of skin graft survival by exogenous ubiquitin. Transplantation. 2006;82(11):1544–1546.
- Saini V, Romero J, Marchese A, et al. Ubiquitin receptor binding and signaling in primary human leukocytes. Commun Integr Biol. 2010;3(6):608–610.
- Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382(6594):829–833.
- Merckelbach S, van der Vorst EPC, Kallmayer M, et al. Expression and cellular localization of CXCR4 and CXCL12 in human carotid atherosclerotic plaques. Thromb Haemost. 2018;118:195–206.
- Mayorga M, Kiedrowski M, Shamhart P, et al. Early upregulation of myocardial CXCR4 expression is critical for dimethyloxalylglycine-induced cardiac improvement in acute myocardial infarction. Am J Physiol Heart Circ Physiol. 2016;310(1):H20–28.
- Weiberg D, Thackeray JT, Daum G, et al. Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using (68)Ga-Pentixafor PET: correlation with cardiovascular risk factors and calcified plaque burden. J Nucl Med. 2018;59(2):266–272.
- Chen M, Jiang YF, Zhang NN, et al. Association between chemokine CXC ligand 12 gene polymorphism (rs1746048) and coronary heart disease: a MOOSE-compliant meta-analysis. Medicine. 2017;96(24):e7179.
- Cai WF, Kang K, Huang W, et al. CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury. J Cell Mol Med. 2015;19(8):1825–1835.
- Singh M, Roginskaya M, Dalal S, et al. Extracellular ubiquitin inhibits beta-AR-stimulated apoptosis in cardiac myocytes: role of GSK-3beta and mitochondrial pathways. Cardiovasc Res. 2010;86(1):20–28.
- Steagall RJ, Daniels CR, Dalal S, et al. Extracellular ubiquitin increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells. Microcirculation. 2014;21(4):324–332.
- Scofield SLC, Daniels CR, Dalal S, et al. Extracellular ubiquitin modulates cardiac fibroblast phenotype and function via its interaction with CXCR4. Life Sci. 2018; 211:8–16.
- Scofield SLC, Dalal S, Lim KA, et al. Exogenous ubiquitin reduces inflammatory response and preserves myocardial function 3 days post-ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2019;316(3):H617–H628.
- Zhang Q, Ai Y, Dong H, et al. Circulating oxidized low-density lipoprotein is a strong risk factor for the early stage of coronary heart disease. IUBMB Life. 2019;71(2):277–282.
- Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.
- Neeland IJ, Patel RS, Eshtehardi P, et al. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J. 2012;164(4):547–552.e1.
- Goldstein G, Scheid M, Hammerling U, et al. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci U S A. 1975;72(1):11–15.
- Chen SM, Zhang HX, Li YG, et al. Expression of ubiquitin in peripheral inflammatory cells from patients with coronary artery disease. J Int Med Res. 2008;36(6):1227–1234.
- Esser N, Paquot N, Scheen AJ. Inflammatory markers and cardiometabolic diseases. Acta Clin Belg. 2015;70(3):193–199.
- Zhao K, Tang M, Wang H, et al. Simultaneous detection of three biomarkers related to acute myocardial infarction based on immunosensing biochip. Biosens Bioelectron. 2019; 126:767–772.
- Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta. 2007;1768(4):952–963.
- Saini V, Staren DM, Ziarek JJ, et al. The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1alpha function through distinct receptor interactions. J Biol Chem. 2011;286(38):33466–33477.
- Saini V, Marchese A, Tang WJ, et al. Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. J Biol Chem. 2011;286(51):44145–44152.
- Fortunato O, Spinetti G, Specchia C, et al. Migratory activity of circulating progenitor cells and serum SDF-1alpha predict adverse events in patients with myocardial infarction. Cardiovasc Res. 2013;100(2):192–200.
- Daniels CR, Foster CR, Yakoob S, et al. Exogenous ubiquitin modulates chronic beta-adrenergic receptor-stimulated myocardial remodeling: role in Akt activity and matrix metalloproteinase expression. Am J Physiol Heart Circ Physiol. 2012;303(12):H1459–H1468.